T2D is characterized by changes in glucose metabolism through the resistance of peripheral tissues to insulin, while T1D is an autoimmune disease in which it is possible to observe the progressive destruction of insulin-producing pancreatic β-cells by an inflammatory cell infiltrate and the production of autoreactive antibodies. The gene discussed is INS; the disease is autoimmune disease.